Capricor Therapeutics (CAPR) EBITDA Margin Growth (5y) (2016 - 2024)
Powered by 
Analysis
Capricor Therapeutics (CAPR) EBITDA Margin Growth (5y) (2016 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Capricor Therapeutics | 543.30 Mn | 543.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 59,892.00 |
| Sep 30, 2024 | 57,043.00 |
| Jun 30, 2024 | 21,153.00 |
| Mar 31, 2024 | 100,672.00 |
| Dec 31, 2023 | 49,952.00 |
| Sep 30, 2023 | 179,185.00 |
| Jun 30, 2023 | 83,279.00 |
| Mar 31, 2023 | 64,735.00 |
| Dec 31, 2022 | -15,087.00 |
| Sep 30, 2022 | 43,499.00 |
| Jun 30, 2021 | -208,251.00 |
| Mar 31, 2021 | -1.23 Mn |
| Dec 31, 2020 | -693,661.00 |
| Sep 30, 2020 | -2.30 Mn |
| Jun 30, 2020 | -675,765.00 |
| Mar 31, 2020 | -94,395.00 |
| Dec 31, 2019 | -53,475.00 |
| Sep 30, 2019 | -103,156.00 |
| Jun 30, 2019 | -36,127.00 |
| Mar 31, 2019 | -99,558.00 |